Literature DB >> 22205198

The roles of neurotrophic factor and Wnt signaling in depression.

B Voleti1, R S Duman.   

Abstract

Depression is a debilitating disease with a lifetime prevalence of ~16% in the American population. In addition to the monoamine hypothesis, altered expressions of neurotrophic factors, growth factors, and Wnt signaling are implicated in the pathophysiology and treatment of depression. This review focuses on intracellular signaling cascades that underlie depression and treatment response.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22205198     DOI： 10.1038/clpt.2011.296

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  28 in total

1.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

Review 2.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

Review 3.  Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function.

Authors:  Lisa R Goldberg; Thomas J Gould
Journal:  Eur J Neurosci       Date:  2018-07-20       Impact factor: 3.386

Review 4.  Exploring Sonic Hedgehog Cell Signaling in Neurogenesis: Its Potential Role in Depressive Behavior.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Monika Sachdeva; Vineet Mehta; Neelam Sharma; Sukhbir Singh; Simona Bungau
Journal:  Neurochem Res       Date:  2021-03-30       Impact factor: 3.996

5.  MiR-221 is involved in depression by regulating Wnt2/CREB/BDNF axis in hippocampal neurons.

Authors:  Nan Lian; Qihui Niu; Yang Lei; Xue Li; Youhui Li; Xueqin Song
Journal:  Cell Cycle       Date:  2018-12-27       Impact factor: 4.534

Review 6.  Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression.

Authors:  Kristie T Ota; Ronald S Duman
Journal:  Neurobiol Dis       Date:  2012-06-09       Impact factor: 5.996

7.  Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2.

Authors:  S J Winham; A B Cuellar-Barboza; A Oliveros; S L McElroy; S Crow; C Colby; D-S Choi; M Chauhan; M Frye; J M Biernacka
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

8.  The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells.

Authors:  Haitao Wang; Xuanhe Zhou; Jianchu Huang; Nan Mu; Zeli Guo; Qiang Wen; Rikang Wang; Shaorui Chen; Zhong-Ping Feng; Wenhua Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

Review 9.  How might circadian rhythms control mood? Let me count the ways...

Authors:  Colleen A McClung
Journal:  Biol Psychiatry       Date:  2013-04-01       Impact factor: 13.382

Review 10.  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-05       Impact factor: 3.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.